Publication:
An open-label trial to assess the safety of regorafenib in turkish patients with metastatic colorectal cancer (mCRC) that progressed on standard therapy (REGARD)

No Thumbnail Available

Date

2015-06-01

Journal Title

Journal ISSN

Volume Title

Publisher

Oxford University Press

Research Projects

Organizational Units

Journal Issue

Abstract

Bu çalışma, 1-4 Temmuz 2015 tarihlerinde Barcelona'da düzenlenen ESMO 17. Dünya Gastrointestinal Kanser Kongresinde bildiri olarak sunulmuştur.

Description

Keywords

Science & technology, Life sciences & biomedicine, Oncology, Oncology

Citation

Collections


Metrikler

Search on Google Scholar


Total Views

0

Total Downloads

0